US2021121537A1PendingUtilityA1

Methods and Compositions for Treating Phenylketonuria

Individually held — no corporate assignee on recordPriority: Jul 17, 2015Filed: Oct 6, 2020Published: Apr 29, 2021
Est. expiryJul 17, 2035(~9 yrs left)· nominal 20-yr term from priority
A61K 45/06C12N 9/0014A61K 9/0053A61K 38/44A61K 38/51C12Y 104/0102C12Y 403/01024A61K 31/195A61P 3/00A61K 9/4891A61K 31/7084
53
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention provides compositions and methods of treating hyperphenylalaninemia (e.g., phenylketonuria) in a subject in need thereof comprising administering to the subject an effective amount of a phenylalanine dehydrogenase (PheDH) polypeptide. The present invention also provides pharmaceutical formulations comprising PheDH for lowering the phenylalanine concentration in the subject (e.g., in the intestines and/or blood).

Claims

exact text as granted — not AI-modified
1 - 37 . (canceled) 
     
     
         38 . An isolated nucleic acid molecule comprising a nucleotide sequence encoding a phenylalanine dehydrogenase polypeptide, or a functional fragment thereof, wherein the encoded polypeptide or functional fragment has at least about 80% sequence identity to a wild-type phenylalanine dehydrogenase enzyme or functional fragment thereof from the organism  Geobacillus thermoglucosidasius.    
     
     
         39 . The isolated nucleic acid molecule of  claim 38 , wherein the nucleotide sequence is a codon-optimized sequence for expression in a host cell 
     
     
         40 . The isolated nucleic acid molecule of  claim 38 , wherein the wild-type phenylalanine dehydrogenase enzyme or functional fragment thereof from the organism  Geobacillus thermoglucosidasius  comprises the amino acid sequence of SEQ ID NO: 1. 
     
     
         41 . The isolated nucleic acid molecule of  claim 38 , wherein the encoded polypeptide or functional fragment thereof has at least about 95% sequence identity to the amino acid sequence of SEQ ID NO: 1. 
     
     
         42 . The isolated nucleic acid molecule of  claim 38 , wherein the encoded polypeptide or functional fragment thereof comprises an amino acid sequence selected from the group consisting of SEQ ID NO: 6, SEQ ID NO: 7, SEQ ID NO: 8, SEQ ID NO: 9, SEQ ID NO: 10, and SEQ ID NO: 11. 
     
     
         43 . The isolated nucleic acid molecule of  claim 38 , wherein the nucleic acid molecule has been codon-optimized for expression in a bacterial cell, a yeast cell, an insect cell, or a mammalian cell. 
     
     
         44 . The isolated nucleic acid molecule of  claim 38 , wherein the nucleic acid molecule has been codon-optimized for expression in  Escherichia coli.    
     
     
         45 . The isolated nucleic acid molecule of  claim 38 , wherein the nucleotide sequence encoding the phenylalanine dehydrogenase polypeptide or functional fragment thereof comprises the nucleotide sequence of SEQ ID NO: 3. 
     
     
         46 . The isolated nucleic acid molecule of  claim 38 , wherein the nucleotide sequence encoding the phenylalanine dehydrogenase polypeptide or functional fragment thereof is operably linked to a promoter sequence. 
     
     
         47 . A plasmid comprising the isolated nucleic acid molecule of  claim 38 . 
     
     
         48 . A host cell comprising the isolated nucleic acid molecule of  claim 38 . 
     
     
         49 . The host cell of  claim 45 , wherein the host cell is  Escherichia coli, Bacillus subtilis, Pichia pastoris , or  Saccharomyces cerevisiae.

Join the waitlist — get patent alerts

Track US2021121537A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.